In summary, the findings from clinical samples suggested that FABP7 was a key molecule that contributed to the accumulation of PI(18:0/20:3), as well as the regulation of the immune checkpoint pathway in primary breast cancer. This evidence concerns the gene FABP7 and breast cancer.